 |
the Joshua Schall Audio ExperienceAuthor: Joshua Schall
Welcome to the Joshua Schall Audio Experience On my podcast, youll hear episodes of my popular short-form Consumer Packaged Goods (CPG) news segment "Consumed", a long-form CPG entrepreneurship interview segment "Formula For:", deeper dive segments "Deep Dish CPG", public speaking engagements, and any of my new and current thoughts that I record specifically for this audio experience! Leave a review on iTunes and let me know what you think! Language: en Genres: Business Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
EXPLOSIVE Demand: How AlzChem Dominates the Global Creatine Market
Wednesday, 7 January, 2026
What does surging demand for creatine and increases in European defense spending have in common? Well, that would be the global specialty chemicals company, AlzChem Group, which is a critical Western supplier in two sought-after (albeit drastically different) sectors. Obviously, my deep domain expertise is far outside Europe’s rising share of NATO defense spending and/or critical raw materials used in propellants for artillery ammunition. But I’ll quickly mention that since AlzChem is the only Western producer of nitroguanidine…it has become a key player in Europe's rearmament efforts. However, why I’m making this particular content piece is to help you better make sense of why suddenly (one day) creatine seemed to be everywhere…being hyped up by every fitness influencer, cognitive health guru, and social commerce affiliate. Hopefully, by gaining knowledge about AlzChem, which is also the sole Western producer of high-purity creatine…marketed mostly under the branded ingredient name Creapure, it provides a distinct layer of insights that I believe will be helpful if you’re interested in trying to understand this “explosive” health trend. Although it is difficult to know exact figures, AlzChem reportedly leads the market by more than a handful of percentage points…supplying slightly over one-quarter of the total global creatine production capacity. Being the only Western producer of creatine, AlzChem holds a unique geopolitical and quality-based "moat" that has proven tremendously powerful in a global supplement market often plagued by opaque ingredient sourcing. While competitors from Asia often compete on price, AlzChem dominates the premium segment niches (like sports or clinical nutrition) where verified batch consistency, absence of harmful contamination, and rigorous traceability are relied on. Furthermore, AlzChem’s long history of consistently supplying pharmaceutical-grade creatine monohydrate basically helps brands explicitly featuring the “Creapure” logo on packaging like MyProtein to justify premium pricing strategies. Additionally, to sustain its market leadership against rising global creatine demand…AlzChem just announced a $140 million investment to build a new, increasingly automated production plant for creatine (and its essential precursors) a few weeks ago. So, even with incremental creatine capacity coming online late last year…AlzChem must invest ahead of the projected double-digit compounded annual growth over the next five years to ensure it can continually meet expected future market expansion. But for those unfamiliar with the recent (and current) market dynamics…no longer constrained to gym bros, creatine is currently undergoing a significant metamorphosis. While the traditional sports nutrition customers (which by the way is harder and harder to label cleanly every day) still account for more than half of global creatine supplement purchases, demand is surging with aging populations seeking muscle preservation, women's health segment (focusing on areas like perimenopause), and even cognitive health applications. Although AlzChem played a vital role in popularizing creatine within that shadowy niche of sports nutrition, it’s remained an industry leader by funding extensive clinical research that competitors rarely match. Therefore, Alzchem is obviously supportive of (and will principally benefit from) an ever-growing body of research with positive results, which has broadened use cases and expanded demographics…making creatine an almost must-have staple for everyone.
